No ownership or control links for UBIPHARM are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is UBIPHARM's risk level?

WhiteIntel flags UBIPHARM as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does UBIPHARM appear across sources?

UBIPHARM is indexed in the WhiteIntel corporate-ownership graph (FR), with a source on every claim.

LIVE · CORPUS

Dossier

■

UBIPHARM

Name: UBIPHARM — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, UBIPHARM, Company, FR

LowLAPSED

CompanyFR

View network JSON / MCPsample

Fig. 01 — Cross-source signature

/01

At a glance

Dimensions on file

Subsidiaries: 4

/02

Key facts

Risk signal

Status: LAPSED

Low

Risk

UBIPHARM is a Company registered in FR (LAPSED).

/03

Ownership & control

Owners / controllers

None in current sources.

Holdings / subsidiaries

UBIPHARM
- PLANETPHARMA· parent· via GLEIF
- LAUNAYPHARM· ultimate parent· via GLEIF

/04

Registry movements

Pulse →

UBIPHARM became parent of LAUNAYPHARM
Registry-recorded parent relationship, effective 24 Sep 2002.
24 Sept 2002
gleif
UBIPHARM became ultimate owner of LAUNAYPHARM
Registry-recorded ultimate parent relationship, effective 24 Sep 2002.
24 Sept 2002
gleif
UBIPHARM became parent of PLANETPHARMA
Registry-recorded parent relationship, effective 30 Nov 1992.
30 Nov 1992
gleif
UBIPHARM became ultimate owner of PLANETPHARMA
Registry-recorded ultimate parent relationship, effective 30 Nov 1992.
30 Nov 1992
gleif

/05

Company profile

GLEIF

Status: LAPSED
Legal form: K65D

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on UBIPHARM. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnakeScore.

Loading tips…